Relmada Therapeutics (RLMD) EV/EBIT: History & Chart

Relmada Therapeutics, Inc.(RLMD)

Biotechnology · Coral Gables, FL

$3.34-0.15 (-4.17%)

Delayed quote: Oct 6, 2026, 12:55 PM EDT

About Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. The company has an agreement with Asarina Pharma AB and Trigone. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.

Coral Gables, FL

17 employees

www.relmada.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Sergio Traversa

View full financials

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
Relmada Therapeutics, Inc. (RLMD)	$349.81M	N/A	N/A	N/A	N/A
Artiva Biotherapeutics, Inc. (ARTV)vs ›	$353.96M	N/A	N/A	N/A	N/A
Orchestra BioMed Holdings, Inc. (OBIO)vs ›	$349.70M	N/A	N/A	N/A	N/A
Fennec Pharmaceuticals Inc. (FENC)vs ›	$355.01M	N/A	55.83x	55.83x	55.83x
Enanta Pharmaceuticals, Inc. (ENTA)vs ›	$355.34M	N/A	45.54x	33.14x	24.49x
Ocugen, Inc. (OCGN)vs ›	$361.15M	N/A	N/A	N/A	N/A
Embecta Corp. (EMBC)vs ›	$361.60M	6.51x	5.53x	9.02x	8.48x
Opus Genetics, Inc. (IRD)vs ›	$362.98M	N/A	N/A	N/A	N/A
Canopy Growth Corporation (CGC)vs ›	$374.20M	N/A	1178.46x	1178.46x	1178.46x
Agenus Inc. (AGEN)vs ›	$329.89M	9.72x	35.72x	35.72x	18.31x

NAME

MARKET CAP

EV/EBIT RATIO

TTM

Relmada Therapeutics, Inc. (RLMD)

$349.81M

N/A

Artiva Biotherapeutics, Inc. (ARTV)vs ›

$353.96M

N/A

Orchestra BioMed Holdings, Inc. (OBIO)vs ›

$349.70M